Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company (NYSE: SMG) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial condition. As an Ohio‑incorporated issuer with common shares listed on the New York Stock Exchange, ScottsMiracle-Gro uses periodic reports and current reports to describe its branded consumer lawn and garden business, indoor and hydroponic growing operations and related financing arrangements.
On this page, you can review core filings such as the annual report on Form 10‑K and quarterly reports on Form 10‑Q, which include segment information for U.S. Consumer, Hawthorne and Other, along with discussions of risk factors, liquidity, capital resources and segment performance. These filings also elaborate on topics referenced in company news releases, such as gross margin trends, leverage, free cash flow and the role of credit facilities and receivables programs in the capital structure.
Current reports on Form 8‑K provide more targeted updates. Recent 8‑K filings describe a Seventh Amended and Restated Credit Agreement establishing senior secured loan facilities, amendments to a master receivables purchase agreement, results of operations for specific quarters and changes to the board of directors and equity award documentation. These filings outline key terms such as leverage and interest coverage covenants, security packages and the use of proceeds for working capital and general corporate purposes.
Definitive proxy statements on Schedule 14A offer detail on corporate governance and executive compensation. ScottsMiracle-Gro’s proxy materials cover board composition, committee responsibilities, director independence, say‑on‑pay proposals, long‑term incentive plan terms, stock ownership guidelines and severance and change‑in‑control arrangements.
This filings page combines real‑time access to new EDGAR submissions with AI‑generated summaries that explain the structure and implications of each document. Users can quickly identify items such as 10‑K and 10‑Q reports, 8‑K current reports, proxy statements and exhibits related to credit agreements or incentive plans, and use the summaries to focus on the sections most relevant to their analysis of SMG.
Johnson Stephen L reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Stephen L. Johnson corrected a previously reported stock award. An earlier Form 4 accidentally left out a grant of 6 Common Shares issued under a board retainer deferral election. As clarified, he actually received 118 Common Shares instead of the 112 originally reported, and now holds 31,245 Common Shares directly.
Sandoval Brian E reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Brian E. Sandoval reported receiving a grant of 472 Common Shares on April 1, 2026 at a price of $61.01 per share. After this compensation-related award, he directly owns 19,195 Common Shares of the company.
Johnson Stephen L reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Stephen L. Johnson received a stock-based retainer grant valued at $7,188. He was awarded 112 Common Shares on the form’s reported date at a reference price of $61.01 per share, issued as Deferred Stock Units in lieu of a cash retainer. Following this grant, Johnson directly holds 31,239 Common Shares, so the award represents a small addition to his existing ownership and reflects routine director compensation rather than an open-market purchase.
Scotts Miracle-Gro Chairman & CEO James Hagedorn settled compensation-related phantom stock into common shares in a routine transaction. On March 30, 2026, he exercised 1,720.158 phantom stock units, receiving an equal number of common shares at a conversion price of $0.00 per share.
Of the resulting 1,720 common shares, 637 shares were withheld at $60.202 per share to cover tax obligations, a non-market “F” code tax-withholding disposition. After these transactions, he directly holds 88,554.9828 common shares and 238,673.3600 phantom stock units, indicating a primarily administrative change in how his compensation is held.
Scheiwer Mark J reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro EVP, CFO & CAO Mark J. Scheiwer received a grant of 124.104 shares of phantom stock on common shares of the company. Following this award, his reported phantom stock balance is 1,354.803 shares.
Each phantom stock share represents the right to receive one common share of Scotts Miracle-Gro or the cash value of that share. These phantom shares are payable in cash after his employment with the company ends, and he may transfer the phantom stock into an alternative investment at any time.
HAGEDORN JAMES reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro Chairman & CEO James Hagedorn received a grant of 3,000.370 phantom stock units tied to common shares. The grant is valued at $65.11 per unit and increases his phantom stock holdings to 240,393.518 units. Each phantom unit represents the right to receive one common share or its cash value, generally payable in cash after his employment with the company ends.
The Vanguard Group filed an amendment reporting 0 shares of Scotts Miracle-Gro Co/The common stock, representing 0% of the class. The filing states that, following an internal realignment effective January 12, 2026, certain Vanguard subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538.
The amendment is signed by Ashley Grim, Head of Global Fund Administration, and lists Vanguard's Malvern, PA address.
Miaritis Nick reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Nick Miaritis reported an equity-related award rather than an open-market trade. He received 64 dividend equivalent rights on March 6, 2026, at a price of $0.00 per right, bringing his directly held dividend equivalent rights to 194.
The filing explains these dividend equivalent rights accrue on deferred or restricted stock units and become exercisable in step with those underlying awards. Each right is described as economically equivalent to one common share of Scotts Miracle-Gro, aligning the director’s compensation more closely with shareholder returns.
Miller Austin Scott reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Austin Scott Miller received an equity-linked award of 48 dividend equivalent rights. These rights were granted at a price of $0.00 per right and increase his directly held dividend equivalent rights to 81 following the transaction. According to the disclosure, each dividend equivalent right is economically equal to one common share and accrues on DSU or RSU grants, becoming exercisable in step with the underlying DSUs or RSUs.
SCOTTS MIRACLE-GRO CO director David C. Evans received an equity-related award tied to dividends on prior grants. On March 6, he acquired 105 dividend equivalent rights at a stated price of $0.00 per right. These rights accrue on DSU or RSU grants and become exercisable proportionately with the underlying awards, with each right economically equivalent to one common share. Following this award, Evans directly holds 552 dividend equivalent rights.